Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytopathies involving mitochondrial complex II.

Brian A C Ackrell1

  • 1Department of Veterans Affairs Medical Center, Molecular Biology Division, San Francisco, CA 94121, USA. baca@itsa.ucsf.edu

Molecular Aspects of Medicine
|September 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment.

The Journal of biological chemistry·2005
Same author

Is defective electron transport at the hub of aging?

Aging cell·2004
See all related articles

Complex II, crucial for the TCA cycle and respiratory chain, has subunits whose defects cause distinct diseases. Mutations in SDHA impair energy production, while SDHB, SDHC, and SDHD mutations lead to paraganglioma.

Area of Science:

  • Biochemistry
  • Cellular Respiration
  • Mitochondrial Biology

Background:

  • Complex II (succinate-ubiquinone oxidoreductase) is the smallest respiratory chain complex, essential for both the TCA cycle and electron transport.
  • It comprises four nuclear-encoded subunits: SdhA, SdhB, SdhC, and SdhD.
  • Bacterial complex II structures and genetic manipulation provide key insights into its function.

Purpose of the Study:

  • To review cytopathies arising from defects or iron-sulfur cluster depletion in human Complex II.
  • To elucidate the distinct disease mechanisms associated with specific subunit mutations.
  • To highlight the role of Complex II subunits in both metabolic function and tumor suppression.

Main Methods:

  • Review of existing literature on Complex II structure and function.

Related Experiment Videos

  • Integration of data from bacterial and bovine Complex II studies.
  • Analysis of recent advances in understanding in vivo cofactor synthesis and disease associations.

    • Main Results:

    • Enzyme depletion and SDHA mutations disrupt TCA cycle activity and cellular energy production.
    • Mutations in SDHB, SDHC, and SDHD are linked to paraganglioma development.
    • SDHC and SDHD represent the first identified tumor suppressor genes within mitochondrial proteins.

    Conclusions:

    • Defects in Complex II subunits lead to a dichotomy of diseases: metabolic dysfunction or tumor formation.
    • Understanding Complex II function is critical for diagnosing and potentially treating associated cytopathies.
    • Mitochondrial protein dysfunction, exemplified by Complex II, has significant implications for human health and disease.